Carestream Health’s Successful R&D Efforts Earn 43 U.S. Patents During 2016; 52 Additional Patents in Other Countries

ROCHESTER, N.Y., Jan. 17 — Carestream Health was awarded 43 new patents from the U.S. Patent and Trademark Office last year for innovation in radiography, cone beam CT imaging, healthcare IT, dental imaging and other areas. The company also received 52 additional patents in European and Asian countries last year. “These patents demonstrate Carestream’s continued success in developing advanced imaging and healthcare IT technologies that serve providers around the world,” said Susan Parulski, Chief Patent Counsel, Carestream. “We are committed to delivering new products and services that can enhance image quality, deliver greater productivity and offer new capabilities to help improve quality of care.” New patents earned by the company’s scientists and engineers include:
•    New medical image capture technologies related to the development of cone beam computed tomography (CT) systems designed for orthopaedic extremity imaging
•    Enhancements to Carestream’s portfolio of healthcare IT systems that manage, store and share patient data and medical imaging exams
•    Continued technology advances in Carestream’s growing portfolio of radiology systems that can enhance diagnostic image quality for a wide range of healthcare providers
•    New technology and features for dental imaging, dental image processing and software and dental restoration systems; and
•    Continued advancements in Carestream laser imagers that provide affordable output of digital X-ray exams onto medical film and paper. The company’s product portfolio includes digital imaging systems for general radiology and specialty areas such as women’s health, orthopaedics and pediatrics; digital laser imagers that output medical images to film and paper; and the latest healthcare IT solutions and cloud-based services for hospitals, clinics and physician practices. Carestream Dental develops and markets film and digital imaging solutions, anesthetics and practice management software.

Click here for an image.Click here for a second image option.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.